93 related articles for article (PubMed ID: 3391876)
1. Antibiotic concentration in suction skin blister fluid and saliva after repeated dosage of erythromycin acistrate and erythromycin base.
Tuominen RK; Männistö PT; Solkinen A; Vuorela A; Pohto P; Haataja H
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():57-65. PubMed ID: 3391876
[TBL] [Abstract][Full Text] [Related]
2. Tonsillar penetration of erythromycin and its 2'-acetyl ester in patients with chronic tonsillitis.
Savolainen S; Männistö PT; Gordin A; Antikainen R; Haataja H; Tuominen RK; Ylikoski J
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():73-84. PubMed ID: 3391878
[TBL] [Abstract][Full Text] [Related]
3. Fate of single oral doses of erythromycin acistrate, erythromycin stearate and pelleted erythromycin base analysed by mass-spectrometry in plasma of healthy human volunteers.
Männistö PT; Taskinen J; Ottoila P; Solkinen A; Vuorela A; Nykänen S
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():33-43. PubMed ID: 3391874
[TBL] [Abstract][Full Text] [Related]
4. Erythromycin acistrate and enterocoated pellets of erythromycin base in acute respiratory infections of hospitalized conscripts.
Gordin A; Salmi HA; Antikainen R
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():93-9. PubMed ID: 3391881
[TBL] [Abstract][Full Text] [Related]
5. Comparison of erythromycin acistrate and enterocoated erythromycin base in acute respiratory infections.
Gordin A; Kalima S; Hulmi S; Mäkelä P; Antikainen R
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():85-92. PubMed ID: 3391879
[TBL] [Abstract][Full Text] [Related]
6. Treatment of respiratory tract infections with erythromycin acistrate and two formulations of erythromycin base.
Wuolijoki E; Flygare U; Hildén M; Hurme J; Järvinen H; Leskinen J; Pynnönen S; Riikonen A; Salomaa V; Seuri M
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():107-12. PubMed ID: 3391872
[TBL] [Abstract][Full Text] [Related]
7. Absorption of erythromycin acistrate and erythromycin base in the fasting and non-fasting state.
Tuominen RK; Männistö PT; Pohto P; Solkinen A; Vuorela A
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():45-55. PubMed ID: 3391875
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of erythromycin, 2'-acetyl erythromycin, and their anhydro forms in plasma and tonsillar tissue after repeated dosage of erythromycin stearate and erythromycin acistrate.
Gordin A; Männistö PT; Antikainen R; Savolainen S; Ylikoski J; Kokkonen P; Rauramaa V
Antimicrob Agents Chemother; 1988 Jul; 32(7):1019-24. PubMed ID: 3190191
[TBL] [Abstract][Full Text] [Related]
9. Erythromycin and 2'-acetyl erythromycin concentrations in plasma and pelvic tissues after repeated doses of erythromycin acistrate.
Lehtonen L; Wikberg R; Karhunen M; Kokkonen P; Tuominen R
Arzneimittelforschung; 1993 Jan; 43(1):53-6. PubMed ID: 8447849
[TBL] [Abstract][Full Text] [Related]
10. Penetration of erythromycin into periapical lesions after repeated doses of erythromycin acistrate and erythromycin stearate: a pilot study.
Tuominen RK; Lehtinen R; Peltola J; Wikberg R; Gordin A; Kokkonen P; Pohto P
Oral Surg Oral Med Oral Pathol; 1991 Jun; 71(6):684-8. PubMed ID: 2062521
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin ethyl succinate: diffusion through interstitial dermal fluid.
Vaillant L; Lorette G; Loulergue J; Audurier A
Eur J Clin Pharmacol; 1987; 33(5):529-30. PubMed ID: 3501376
[TBL] [Abstract][Full Text] [Related]
12. Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers.
Warlich R; Korting HC; Schäfer-Korting M; Mutschler E
Antimicrob Agents Chemother; 1990 Jan; 34(1):78-81. PubMed ID: 2327762
[TBL] [Abstract][Full Text] [Related]
13. Cefodizime penetration into skin suction blister fluid following a single intravenous dose.
Schäfer-Korting M; Korting HC; Maass L; Klesel N; Grigoleit HG; Mutschler E
Eur J Clin Pharmacol; 1986; 30(3):295-8. PubMed ID: 3732363
[TBL] [Abstract][Full Text] [Related]
14. Effect of food on absorption and hydrolysis of erythromycin acistrate.
Järvinen A; Nykänen S; Mattila J; Haataja H
Arzneimittelforschung; 1992 Jan; 42(1):73-6. PubMed ID: 1586385
[TBL] [Abstract][Full Text] [Related]
15. Hydrolysis of 2'-esters of erythromycin.
Taskinen J; Ottoila P
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():1-8. PubMed ID: 3391870
[TBL] [Abstract][Full Text] [Related]
16. The influence of food on the bioavailability of new formulations of erythromycin stearate and base.
Rutland J; Berend N; Marlin GE
Br J Clin Pharmacol; 1979 Oct; 8(4):343-7. PubMed ID: 508509
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of erythromycin acistrate and erythromycin stearate in acute skin infections of patients with atopic eczema.
Salo OP; Gordin A; Brandt H; Antikainen R
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():101-6. PubMed ID: 3391871
[TBL] [Abstract][Full Text] [Related]
18. Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.
Schäfer-Korting M; Korting HC; Mutschler E
Eur J Clin Pharmacol; 1985; 29(1):109-13. PubMed ID: 4054199
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans.
Ducci M; Scalori V; del Tacca M; Soldani G; Bernardini C; Grothe E; Bertelli A
Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):494-7. PubMed ID: 7298242
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva.
Geerdes-Fenge HF; Goetschi B; Rau M; Borner K; Koeppe P; Wettich K; Lode H
Eur J Clin Pharmacol; 1997; 53(2):127-33. PubMed ID: 9403284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
